Home・Lista de Ações・Twist Bioscience Corp

Twist Bioscience Corp

Abrir

SetorSaúde

126.49 -0.17

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

125.24

Máximo

129.19

Indicadores-chave
By Trading Economics
Rendimento	9M -35M
Vendas	7.7M 118M
EPS	-0.56
Margem de lucro	-29.61
Funcionários	979
EBITDA	9.8M -28M

Dividendos
By Acuity
Próximos Ganhos	13 de nov. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	1.5B 7.8B
Abertura anterior	126.66
Fecho anterior	126.49

Sentimento de Notícias

By Acuity

50%

146 / 339 Ranking em Healthcare

Twist Bioscience Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

10 de set. de 2026, 23:01 UTC

Twist Bioscience Corp shares are trading higher in after-market hours. No specific news was identified to explain the movement.

9 de set. de 2026, 20:07 UTC

News

Correlated Moves

Twist Bioscience shares are lower as BWS Financial initiates coverage with a Sell rating, contrasting UBS's Neutral rating and higher price target of $144.00.

8 de set. de 2026, 20:07 UTC

News

Social Media

Twist Bioscience Corp shares are higher, driven by increased recognition of AI applications in healthcare and a "Moderate Buy" consensus rating from brokerages.

3 de set. de 2026, 19:36 UTC

News

Twist Bioscience reported $118.4 million in Q3 revenue and raised its guidance, yet shares are lower, continuing a five-session decline.

2 de set. de 2026, 23:06 UTC

Twist Bioscience Corp. shares are lower in after-market hours, extending a trend of five consecutive daily declines. Earlier, the stock briefly rose before falling again.

1 de set. de 2026, 19:56 UTC

Correlated Moves

Twist Bioscience Corp shares are lower amid broader market pressures and rising Treasury yields. The Russell 2000 Index also declined during Tuesday's session.

31 de ago. de 2026, 23:46 UTC

Twist Bioscience Corp shares are lower in after-market trading, following no specific news. The stock remains above its 20-day moving average.

28 de ago. de 2026, 22:51 UTC

Twist Bioscience shares are higher in after-market trading. Rising Treasury yields may be influencing investor sentiment in the biotechnology sector.

27 de ago. de 2026, 23:02 UTC

Twist Bioscience shares are higher in after-market hours, recovering from earlier losses. Jobless claims data suggests strength in the labor market.

26 de ago. de 2026, 19:36 UTC

Twist Bioscience Corp shares are trading higher today, maintaining a position near the upper end of their one-month range. No specific news has been identified.

25 de ago. de 2026, 23:06 UTC

Twist Bioscience Corp shares are higher in after-market hours, rebounding from a post-close low amid broader market support from falling crude oil prices and treasury yields.

24 de ago. de 2026, 23:51 UTC

Twist Bioscience Corp shares are higher in after-market trading, maintaining gains from earlier in the session and staying above key moving averages.

21 de ago. de 2026, 23:46 UTC

Twist Bioscience Corp shares are lower in after-market trading, despite remaining well above their 20-day moving average and last month's price levels.

20 de ago. de 2026, 23:46 UTC

Twist Bioscience Corp shares are lower in after-market trading. Broader market pressures, including rising crude oil prices and geopolitical tensions, may be influencing sentiment.

19 de ago. de 2026, 23:06 UTC

News

Correlated Moves

Twist Bioscience Corp shares are lower in after-market hours following a critical short report from Scorpion Capital questioning the company's AI-driven protein design strategy.

18 de ago. de 2026, 23:21 UTC

Twist Bioscience Corp shares are higher in after-market trading, maintaining an upward trend and positioned above its 20-day moving average.

17 de ago. de 2026, 22:36 UTC

Twist Bioscience Corp shares are slightly higher in after-market hours, maintaining strong performance above their 20-day moving average despite earlier declines.

14 de ago. de 2026, 19:06 UTC

Twist Bioscience shares are lower today, continuing a decline since Thursday amid broader market volatility and recent U.S. retail sales data.

13 de ago. de 2026, 23:06 UTC

Correlated Moves

Twist Bioscience Corp shares are lower in after-market trading, influenced by broader market declines and recent macroeconomic data on jobless claims and producer prices.

12 de ago. de 2026, 19:16 UTC

Twist Bioscience Corp is higher Wednesday, tracking broader U.S. stock gains amid strength in AI sectors following positive quarterly results from CoreWeave and Super Micro Computer.

11 de ago. de 2026, 23:46 UTC

Correlated Moves

Twist Bioscience Corp shares declined during after-market hours, following a drop in the Russell 2000 Index amid investor caution ahead of the consumer price index report.

10 de ago. de 2026, 20:03 UTC

News

Social Media

Twist Bioscience Corp shares are higher today, buoyed by positive social media sentiment and a notable increase in trading volume since Friday's close.

7 de ago. de 2026, 19:51 UTC

Twist Bioscience Corp shares are higher during Friday's session, with strong market activity and unusually high volume. No specific news explains this movement.

6 de ago. de 2026, 22:56 UTC

Twist Bioscience Corp shares are higher in after-market trading, reflecting positive momentum since Thursday's close amid broader economic data indicating labor market strength.

5 de ago. de 2026, 23:56 UTC

Twist Bioscience Corp shares rose in after-market trading, despite earlier declines. Market sentiment was affected by a disappointing ADP employment report.

4 de ago. de 2026, 23:01 UTC

News

Twist Bioscience announced a $250 million public offering, raising concerns over potential dilution. Shares are trading lower in after-market hours following the announcement.

3 de ago. de 2026, 22:16 UTC

Twist Bioscience Corp shares are lower in after-market hours, despite an initial gain following Monday's close. No specific news was identified to explain the decline.

31 de jul. de 2026, 19:56 UTC

Twist Bioscience shares are higher, reflecting positive sentiment in biotechnology amid strong results from major technology firms like Amazon.

30 de jul. de 2026, 10:16 UTC

Twist Bioscience Corp is trading slightly higher in pre-market hours, recovering from a decline in the previous session amid broader tech stock volatility.

29 de jul. de 2026, 19:36 UTC

Correlated Moves

Macro Event

Twist Bioscience shares are lower today, influenced by a declining Russell 2000 Index and persistent inflation concerns amid steady interest rates.

Comparação entre Pares

Variação de preço

Twist Bioscience Corp Previsão

Consenso de Avaliação

By TipRanks

Compra Moderada

11 ratings

Comprar

Manter

Vender

Com base em 11 analistas que deram avaliações de ações para Twist Bioscience Corp - Dist nos últimos 3 meses.

Sentimento

By Acuity

146 / 339 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.